Economic Implications of Transcatheter Aortic Valve Replacement in Patients at Intermediate Surgical Risk.
From Harvard Clinical Research Institute, Boston, MA, and Lahey Hospital & Medical Center, Burlington, MA (M.R.R.); and Saint Luke's Mid America Heart Institute, University of Missouri-Kansas City (S.J.B., D.J.C.).
Matthew R
MR
Reynolds
From Harvard Clinical Research Institute, Boston, MA, and Lahey Hospital & Medical Center, Burlington, MA (M.R.R.); and Saint Luke's Mid America Heart Institute, University of Missouri-Kansas City (S.J.B., D.J.C.).
Suzanne J
SJ
Baron
From Harvard Clinical Research Institute, Boston, MA, and Lahey Hospital & Medical Center, Burlington, MA (M.R.R.); and Saint Luke's Mid America Heart Institute, University of Missouri-Kansas City (S.J.B., D.J.C.). dcohen@saint-lukes.org.
David J
DJ
Cohen
D001024:Aortic Valve Stenosis / Q000191:economics* / Q000401:mortality / Q000503:physiopathology / Q000601:surgery*; D000066491:Clinical Decision-Making; D003362:Cost-Benefit Analysis; D017048:Health Care Costs; D006801:Humans; D007902:Length of Stay / Q000191:economics; D018803:Models, Economic; D011183:Postoperative Complications / Q000191:economics / Q000628:therapy; D019057:Quality-Adjusted Life Years; D012307:Risk Factors; D065467:Transcatheter Aortic Valve Replacement / Q000009:adverse effects / Q000191:economics* / Q000401:mortality; D016896:Treatment Outcome
aortic valve stenosis; cost effectiveness; cost-benefit analysis; transcatheter aortic valve implantation